Evidence map›Paper›PMID 21550985›Full record

ArticleThe Journal of biological chemistry2011

Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10.

Delia Susan-Resiga, Rachid Essalmani, Josée Hamelin, Marie-Claude Asselin, Suzanne Benjannet, Ann Chamberland, Robert Day, Dorota Szumska, Daniel Constam, Shoumo Bhattacharya and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Diagnostic and prognostic utility of bone morphogenetic protein 10 in acute dyspnea: a cohort study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Frontiers in endocrinology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Role of the TGF-β Superfamily in Myocardial Infarction.Frontiers in cardiovascular medicine · 2019
    Review
  19. Article
  20. Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.Laboratory investigation; a journal of technical methods and pathology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Delia Susan-ResigaLaboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Université de Montréal, Montreal, Quebec H2W 1R7, Canada.
Rachid Essalmani
Josée Hamelin
Marie-Claude Asselin
Suzanne Benjannet
Ann Chamberland
Robert Day
Dorota Szumska
Daniel Constam
Shoumo Bhattacharya
Annik Prat
Nabil G Seidah
Université de Montréal · CAMontreal Clinical Research Institute · CACentre for Human Genetics · GBÉcole Polytechnique Fédérale de Lausanne · CHUniversité de Sherbrooke · CAUniversity of Oxford · GB

Funding

British Heart Foundation CH/09/003British Heart Foundation PG/07/045/22690British Heart Foundation RG/10/17/28553CIHR MOP-44363Wellcome Trust 075491/Z/04Wellcome Trust 090532
6 · The paper itself

Abstract

Bone morphogenetic protein 10 (BMP10) is a member of the TGF-β superfamily and plays a critical role in heart development. In the postnatal heart, BMP10 is restricted to the right atrium. The inactive pro-BMP10 (∼60 kDa) is processed into active BMP10 (∼14 kDa) by an unknown protease. Proteolytic cleavage occurs at the RIRR(316)↓ site (human), suggesting the involvement of proprotein convertase(s) (PCs). In vitro digestion of a 12-mer peptide encompassing the predicted cleavage site with furin, PACE4, PC5/6, and PC7, showed that furin cleaves the best, whereas PC7 is inactive on this peptide. Ex vivo studies in COS-1 cells, a cell line lacking PC5/6, revealed efficient processing of pro-BMP10 by endogenous PCs other than PC5/6. The lack of processing of overexpressed pro-BMP10 in the furin- and PACE4-deficient cell line, CHO-FD11, and in furin-deficient LoVo cells, was restored by stable (CHO-FD11/Fur cells) or transient (LoVo cells) expression of furin. Use of cell-permeable and cell surface inhibitors suggested that endogenous PCs process pro-BMP10 mostly intracellularly, but also at the cell surface. Ex vivo experiments in mouse primary hepatocytes (wild type, PC5/6 knock-out, and furin knock-out) corroborated the above findings that pro-BMP10 is a substrate for endogenous furin. Western blot analyses of heart right atria extracts from wild type and PACE4 knock-out adult mice showed no significant difference in the processing of pro-BMP10, implying no in vivo role of PACE4. Overall, our in vitro, ex vivo, and in vivo data suggest that furin is the major convertase responsible for the generation of BMP10.

Indexed as

AnimalsBone Morphogenetic ProteinsChlorocebus aethiopsCOS CellsFurinGene Knockdown TechniquesHeart VentriclesHumansMiceMice, KnockoutMyocardiumOrgan SpecificitySerine Proteinase InhibitorsBMP10 protein, humanBmp10 protein, mouseBone Morphogenetic ProteinsFurinSerine Proteinase Inhibitors

Identifiers

PMID21550985
PMCPMC3123046
OpenAlexW2022674779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.